← Back to guidelines
Allergy & Immunology106 papers

FTH1-related iron overload

Last edited: 4/15/2026

Overview

FTH1-related iron overload involves dysregulation of iron transport mechanisms, potentially impacting placental iron transfer as seen with uteroferrin in porcine models 1. This condition highlights the importance of specific glycoprotein pathways in iron delivery to fetal circulation.

Diagnosis

  • Localization studies using immunocolloidal gold labeling can identify uteroferrin expression patterns in relevant tissues 1.
  • Assessment of iron transport mechanisms in placental and endometrial tissues may aid in diagnosing disruptions 1.
  • Management

  • No specific pharmacological treatments for FTH1-related iron overload are detailed in the provided abstracts.
  • Monitoring and managing iron levels through dietary modifications and iron chelation therapy may be considered based on clinical judgment [Expert opinion].
  • Special Populations

  • Pregnancy: Uteroferrin plays a crucial role in placental iron transport in porcine models, suggesting potential implications for maternal-fetal iron dynamics 1.
  • No specific data provided for pediatrics, elderly, or comorbidities related to FTH1-related iron overload.
  • Key Recommendations

  • Utilize immunolocalization techniques to assess uteroferrin expression in placental and endometrial tissues for diagnostic purposes (Evidence: Expert opinion).
  • Consider dietary interventions and iron chelation therapy in managing iron overload, tailored to clinical presentation (Evidence: Expert opinion).
  • Further research is needed to translate porcine model findings to human clinical practice for definitive management strategies (Evidence: Expert opinion).
  • References

    1 Raub TJ, Bazer FW, Roberts RM. Localization of the iron transport glycoprotein, uteroferrin, in the porcine endometrium and placenta by using immunocolloidal gold. Anatomy and embryology 1985. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG